Dr. Ashish Sarraju and Dr. C. Michael Gibson Discuss: CTX310 (CRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3 for Severe Hypertriglyceridemia: Results from Phase 1b Trial) November 9, 2026 2026 | AHA | Slides | Trial | Uncategorized | Video Sarraju AHA 2026Download Disclosures: TBD Article Navigation Dr. Wei Zhang and Dr. C. Michael Gibson Discuss: SUPERIOR (Sacubitril/Valsartan for Preventing Recurrence of Atrial Fibrillation After Catheter Ablation in Patients With Hypertension: A Multicenter, Randomized Controlled Trial) Dr. Marat Fudim and Dr. C. Michael Gibson Discuss: Recover-Autonomic Platform Trial (Results from Primary Analysis of the Coordinated versus Usual Nonpharmacologic Care for Postural Orthostatic Tachycardia Syndrome in Long COVID: A Pooled Analysis from the Recover-Autonomic Platform Trial)
